Latest news with #Mansion
Epoch Times
17-05-2025
- Health
- Epoch Times
Regain Emotional Harmony and Alleviate Anger With This Acupoint
We've all had moments where we said something we didn't mean or acted on impulse, only to regret it later. Psychology tells us such reactions are related to unresolved trauma or stress. Biomedicine points to neurotransmitter surges and overactive brain circuits. Traditional Chinese medicine (TCM) offers a different lens, linking emotional outbursts to the energetic state of the heart. When the heart is overwhelmed by internal heat, the Lesser Mansion (Shao Fu, HT8), an acupoint on your palm, provides a practical and time-tested tool for release and restoration. A Classical Remedy With Lasting Relevance Shao Fu was first documented in 'Zhen Jiu Jia Yi Jing,' the earliest known systematic text on acupuncture and moxibustion (a gentle heat therapy with dried mugwort) , giving the point a long and respected lineage in TCM. Shao Fu is classified as a Ying-Spring point and is particularly effective at clearing heat from the Heart meridian. In TCM, heat in the Heart doesn't just show up as fever or inflammation—it can appear as anger, irritability, and even a sharp tongue during emotional outbursts.
Business Upturn
14-05-2025
- Business
- Business Upturn
Tilaknagar Industries Q4FY25 results: Net profit soars 95.7% YoY to Rs 77 crore; revenue up 13.1% to Rs 406 crore
By News Desk Published on May 14, 2025, 21:26 IST Tilaknagar Industries Ltd. (TI), the maker of Mansion House Brandy, reported its highest-ever quarterly EBITDA and strong earnings growth for the quarter ended March 31, 2025 (Q4FY25), buoyed by robust sales across key southern markets. The company's net profit (excluding exceptional items) surged 95.7% year-on-year to ₹77 crore, up from ₹40 crore in Q4FY24. Revenue from operations rose 13.1% to ₹406 crore, supported by a 20.1% volume growth, particularly from Andhra Pradesh, Karnataka, and Tamil Nadu. The EBITDA came in at ₹78 crore, registering a 62.6% increase. Adjusted for subsidy income, EBITDA stood at ₹65 crore, translating to a 35.5% YoY growth, with margins improving 319 basis points to 16.6%. Full-year performance (FY25 vs FY24): Revenue: ₹1,434 crore vs ₹1,394 crore (up 2.9%) EBITDA: ₹255 crore vs ₹185 crore (up 37.4%) PAT (excluding exceptional items): ₹230 crore vs ₹141 crore (up 62.9%) Net cash position: ₹107 crore as of March 31, 2025 Chairman & MD Amit Dahanukar said, 'This was our strongest quarter ever. Our focused growth in Andhra Pradesh and other southern markets, along with operating leverage and disciplined cost management, helped us deliver exceptional profitability.' The company also recommended a dividend of ₹1 per share for FY25. Other updates: Monarch Legacy Edition Brandy won a Bronze at the London Spirits Competition 2025 Commenced marketing of Samsara Gin under a user agreement with Spaceman Spirits Lab Disclaimer: This report is based on official company filings and is for informational purposes only. It does not constitute investment advice. News desk at
